Keys to conducting a credible pharmacoeconomic study Katherine V Mann Newsletter Article 16 February 2013 Pages: 3 - 4
Questioning the credibility of clinical & economic analyses Newsletter Article 16 February 2013 Pages: 4 - 4
Healthcare outcomes essential for quality decision-making? Newsletter Article 16 February 2013 Pages: 6 - 6
Ensuring appropriate antibacterial use for paediatric infection Newsletter Article 16 February 2013 Pages: 7 - 7
Resource utilisation and costs in migraine sufferers Newsletter Article 16 February 2013 Pages: 7 - 7
Health economics important in managing acid-related diseases Newsletter Article 16 February 2013 Pages: 8 - 9
A cost-effective alternative for nonsmall cell lung cancer Newsletter Article 16 February 2013 Pages: 9 - 9
Crucial elements to consider in treating depression … Newsletter Article 16 February 2013 Pages: 10 - 10
ISMN more cost effective than ISDN and transdermal nitroglycerin Newsletter Article 16 February 2013 Pages: 12 - 12
Importance of measuring utility in patients with RA Newsletter Article 16 February 2013 Pages: 12 - 13
Mail order pharmacy sales hit $US11 billion by 1997 Newsletter Article 16 February 2013 Pages: 16 - 16